{"id":"https://openalex.org/W1600409575","doi":"https://doi.org/10.1046/j.1365-2710.1998.00138.x","title":"Evaluation of drug usage and expenditure in a hospital diabetes clinic","display_name":"Evaluation of drug usage and expenditure in a hospital diabetes clinic","publication_year":1998,"publication_date":"1998-02-01","ids":{"openalex":"https://openalex.org/W1600409575","doi":"https://doi.org/10.1046/j.1365-2710.1998.00138.x","mag":"1600409575","pmid":"https://pubmed.ncbi.nlm.nih.gov/9756112"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2710.1998.00138.x","doi":"https://doi.org/10.1046/j.1365-2710.1998.00138.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2710.1998.00138.x","pdf_url":null,"source":{"id":"https://openalex.org/S156693432","display_name":"Journal of Clinical Pharmacy and Therapeutics","issn_l":"0269-4727","issn":["0269-4727","1365-2710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Pharmacy and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111468110","display_name":"Song Wu","orcid":"https://orcid.org/0009-0002-9389-4092","observed_orcids":["https://orcid.org/0009-0002-9389-4092"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"S. Y. B. Wu","raw_affiliation_strings":["Department of Pharmacy, The Chinese University of Hong Kong, Shatin, New Territories","Department of Pharmacy, The Chinese University of Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The Chinese University of Hong Kong, Shatin, New Territories","institution_ids":["https://openalex.org/I177725633"]},{"raw_affiliation_string":"Department of Pharmacy, The Chinese University of Hong Kong","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"middle","author":{"id":null,"display_name":"B. C. H. Lung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"B. C. H. Lung","raw_affiliation_strings":["Department of Pharmacy, The Chinese University of Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The Chinese University of Hong Kong","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112219149","display_name":"S. Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"S. Chang","raw_affiliation_strings":["Department of Pharmacy, The Chinese University of Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The Chinese University of Hong Kong","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089480230","display_name":"S. C. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114914","display_name":"Prince of Wales Hospital","ror":"https://ror.org/02827ca86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I4210114914"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"S. C. Lee","raw_affiliation_strings":["Department of Pharmacy, The Prince of Wales Hospital, Shatin, New Territories, Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The Prince of Wales Hospital, Shatin, New Territories, Hong Kong","institution_ids":["https://openalex.org/I4210114914"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036805172","display_name":"Julia Critchley","orcid":"https://orcid.org/0000-0002-5248-4188","observed_orcids":["https://orcid.org/0000-0002-5248-4188"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"J. A. J. H. Critchley","raw_affiliation_strings":["Department of Clinical Pharmacology, The Chinese University of Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Chinese University of Hong Kong","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091832416","display_name":"Juliana C.N. Chan","orcid":"https://orcid.org/0000-0003-1325-1194","observed_orcids":["https://orcid.org/0000-0003-1325-1194"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"J. C. N. Chan","raw_affiliation_strings":["Department of Clinical Pharmacology, The Chinese University of Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Chinese University of Hong Kong","institution_ids":["https://openalex.org/I177725633"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2700,"currency":"USD","value_usd":2700},"apc_paid":null,"fwci":0.2237,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.53102881,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"23","issue":"1","first_page":"49","last_page":"56"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8809000253677368,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8809000253677368,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.01979999989271164,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.9810000061988831},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8450000286102295},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.9070000052452087},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-expenditure","display_name":"drug expenditure","score":0.7419999837875366},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8809999823570251},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9380000233650208},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.7979999780654907},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.8270000219345093},{"id":"https://openalex.org/keywords/gliclazide","display_name":"gliclazide","score":0.9309999942779541},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9480000138282776},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9639999866485596},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.968999981880188},{"id":"https://openalex.org/keywords/gemfibrozil","display_name":"gemfibrozil","score":0.9929999709129333},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.5680000185966492},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.932613730430603},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8454727530479431},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7193616628646851},{"id":"https://openalex.org/C2777448766","wikidata":"https://www.wikidata.org/wiki/Q290001","display_name":"Gliclazide","level":3,"score":0.7120844125747681},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.6668015122413635},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5648550391197205},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5532035827636719},{"id":"https://openalex.org/C2778670441","wikidata":"https://www.wikidata.org/wiki/Q384295","display_name":"Gemfibrozil","level":3,"score":0.5410929322242737},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46656671166419983},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.450672447681427},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.44177132844924927},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4336875081062317},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.43245118856430054},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.42959901690483093},{"id":"https://openalex.org/C2780192228","wikidata":"https://www.wikidata.org/wiki/Q575890","display_name":"Antihypertensive drug","level":3,"score":0.411062628030777},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.41031917929649353},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21925196051597595},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.19845345616340637},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.11967676877975464}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006723","descriptor_name":"Hong Kong","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010044","descriptor_name":"Outpatient Clinics, Hospital","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017723","descriptor_name":"Drug Utilization Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D048909","descriptor_name":"Diabetes Complications","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2710.1998.00138.x","doi":"https://doi.org/10.1046/j.1365-2710.1998.00138.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2710.1998.00138.x","pdf_url":null,"source":{"id":"https://openalex.org/S156693432","display_name":"Journal of Clinical Pharmacy and Therapeutics","issn_l":"0269-4727","issn":["0269-4727","1365-2710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Pharmacy and Therapeutics","raw_type":"journal-article"},{"id":"pmid:9756112","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9756112","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacy and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W68942930","https://openalex.org/W1968219575","https://openalex.org/W1970083430","https://openalex.org/W1974657065","https://openalex.org/W1978205142","https://openalex.org/W1984222773","https://openalex.org/W2001112180","https://openalex.org/W2007449953","https://openalex.org/W2014740063","https://openalex.org/W2041154843","https://openalex.org/W2052468277","https://openalex.org/W2055704889","https://openalex.org/W2056347227","https://openalex.org/W2071716799","https://openalex.org/W2077333111","https://openalex.org/W2077634158","https://openalex.org/W2077945116","https://openalex.org/W2088065710","https://openalex.org/W2101251503","https://openalex.org/W2115871755","https://openalex.org/W2130466611","https://openalex.org/W2133971646","https://openalex.org/W2141887336","https://openalex.org/W2145796003","https://openalex.org/W2154513595","https://openalex.org/W2170308529","https://openalex.org/W2261014454","https://openalex.org/W2312388685","https://openalex.org/W2615684303","https://openalex.org/W2752336761","https://openalex.org/W2769264260","https://openalex.org/W4238678736"],"related_works":["https://openalex.org/W2119575222","https://openalex.org/W1980574025","https://openalex.org/W2312471786","https://openalex.org/W4410497157","https://openalex.org/W2098305397","https://openalex.org/W2116874807","https://openalex.org/W7099610273","https://openalex.org/W2261014454","https://openalex.org/W4205122323","https://openalex.org/W2791263164"],"abstract_inverted_index":{"BACKGROUND:":[0],"Diabetes":[1],"mellitus":[2],"is":[3],"a":[4,33,115,263],"major":[5,264],"public":[6],"health":[7,268,312],"problem":[8],"and":[9,14,28,64,73,130,145,170,193,208,214,220,239,247,279,298],"often":[10],"coexists":[11],"with":[12,124,131,140,173],"hypertension":[13],"dyslipidaemia.":[15],"A":[16],"prescription-based":[17],"survey":[18],"was":[19,40,112,155,164],"conducted":[20],"to":[21,80,294,318],"examine":[22],"the":[23,47,74,82,88,149,181,199,223,235,242,252,267],"use":[24,258],"of":[25,70,96,222,234,251,259,274,288,300,307],"antidiabetic,":[26],"antihypertensive":[27,63,187,215,277],"lipid":[29,280],"lowering":[30,281],"drugs":[31,151,175,203,216,229,245,261,278,282],"in":[32,107,118,122,126,133,157,166,171,176,204,232],"hospital":[34],"diabetes":[35,48],"clinic.":[36],"The":[37,67,212,257,271,305],"expenditure":[38],"incurred":[39],"also":[41],"evaluated.":[42],"METHOD:":[43],"Prescriptions":[44],"issued":[45],"from":[46],"clinic":[49],"were":[50,57,78,94,105,148,198,230,241],"collected":[51],"for":[52,218,249],"4":[53],"consecutive":[54],"weeks.":[55],"Drugs":[56],"categorized":[58],"into":[59],"three":[60],"main":[61,150],"classes--antidiabetic,":[62],"lipid-lowering":[65],"drugs.":[66,101,188],"unit":[68],"cost":[69],"each":[71],"drug":[72,84,225,254,285],"total":[75,83,224,253],"amount":[76],"prescribed":[77,106,156,165,202,231,246],"used":[79,113,303],"estimate":[81],"costs.":[85],"RESULTS:":[86],"During":[87],"4-week":[89],"study":[90],"period,":[91],"534":[92,182],"prescriptions":[93],"collected,":[95],"which":[97],"520":[98],"contained":[99,186],"antidiabetic":[100,213,260],"Oral":[102],"hypoglycaemic":[103],"agents":[104,192],"379":[108],"patients":[109,129,135,138,160,169,178,275],"(72.9%).":[110],"Sulphonylurea":[111],"as":[114],"single":[116],"agent":[117],"119":[119],"(22.9%)":[120],"patients,":[121],"combination":[123,172,209],"metformin":[125],"219":[127],"(42%)":[128,185],"insulin":[132],"17":[134],"(3.3%).":[136],"Among":[137],"treated":[139],"sulphonylureas":[141],"(n=342),":[142],"glibenclamide":[143],"(47.7%)":[144],"gliclazide":[146],"(30.7%)":[147],"prescribed.":[152],"Metformin":[153],"monotherapy":[154,206],"only":[158],"31":[159],"(6%).":[161],"Insulin":[162],"treatment":[163],"141":[167],"(27%)":[168],"oral":[174],"23":[177],"(4.5%).":[179],"Of":[180],"prescriptions,":[183],"225":[184],"Calcium":[189],"channel":[190],"blocking":[191],"angiotensin":[194],"converting":[195],"enzyme":[196],"inhibitors":[197],"most":[200,243],"commonly":[201],"both":[205],"(n=155)":[207],"therapy":[210],"(n=70).":[211],"accounted":[217,248],"45%":[219],"39%":[221],"expenditure,":[226],"respectively.":[227],"Lipid-lowering":[228],"8%":[233],"diabetic":[236],"patients.":[237],"Simvastatin":[238],"gemfibrozil":[240],"common":[244],"12%":[250],"expenditure.":[255,286],"CONCLUSION:":[256],"represents":[262],"burden":[265],"on":[266,311],"care":[269,313],"system.":[270],"high":[272],"proportions":[273],"requiring":[276],"further":[283],"increase":[284],"Most":[287],"these":[289,308],"treatments":[290],"have":[291],"been":[292],"shown":[293],"improve":[295],"clinical":[296],"outcomes":[297],"quality":[299],"life,":[301],"if":[302],"appropriately.":[304],"impacts":[306],"long-term":[309],"medications":[310],"financing":[314],"require":[315],"careful":[316],"evaluation":[317],"assess":[319],"their":[320],"cost-effectiveness.":[321]},"counts_by_year":[{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}